National Veterans Non-Profit Operation Song Appoints Jon Foti as CEO

With Expansion, the Organization Begins Search for New Office Space in Nashville TN NASHVILLE Tenn., Feb. 16, 2024 /PRNewswire/ — Operation Song®, the 501(c)(3) non-profit that pairs veterans and active-duty military with professional songwriters to tell their stories through song, announces the appointment of Jon Foti as Chief Executive Officer (CEO). Foti assumes the role after … Read more

WellBiz Brands Inc. Names Franchise Industry Veteran Amanda Clark as CEO

Experienced Executive to Drive Next Phase of Growth for Leading Franchise Platform of Best-in-Class Beauty and Wellness Brands DENVER, Feb. 15, 2024 /PRNewswire/ — WellBiz Brands Inc. (“WellBiz Brands”), the pre-eminent beauty and wellness franchise platform, today announced that Amanda Clark, a seasoned franchise industry executive, has been appointed Chief Executive Officer, effective March 12, 2024. … Read more

Global Hearing Aids Market Insights 2024-2029

DUBLIN, Feb. 14, 2024 /PRNewswire/ — The “Global Hearing Aids Market – Focused Insights 2024-2029” report has been added to  ResearchAndMarkets.com’s offering. The global hearing aids market is forecast to reach $8.55 billion by 2029 from US$6.66 Billion in 2023, growing at a CAGR of 4.25%, . The market growth can be attributed to the growing … Read more

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

OSAKA, Japan, Feb. 14, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has entered into a drug discovery collaboration and option agreement with Shattuck Labs, Inc. (Austin, Texas, USA; CEO: Taylor Schreiber; “Shattuck”) to generate bifunctional fusion proteins for pathways involved in autoimmune and inflammatory … Read more

New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution

New bisulfite-free system allows scientists to accurately and sensitively discriminate 5hmC from un-modified cytosine and 5mC from a wide range of DNA inputs, advancing epigenetics research. IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ — New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific … Read more

Meridian Bioscience Senior Director of R&D, Dr. Dan (Dror) Siman-Tov, to Spotlight Lateral Flow Innovations at the Advanced Lateral Flow Conference 2024

CINCINNATI, Feb. 12, 2024 /PRNewswire/ — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, is proud to announce that Dr. Dan (Dror) Siman-Tov, Ph.D., MBA, Senior Director of R&D, Diagnostics, will be presenting at the Advanced Lateral Flow Conference 2024. The event is scheduled to take place at … Read more

NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

Companies continue to work collaboratively to advance NRX-101 through registrational trials NRx remains eligible for an additional $324 million in development and sales milestones, as well as tiered double-digit royalties upon approval and commercialization of NRX-101. Payment materially extends the Company’s cash runway RADNOR, Pa., Feb. 11, 2024 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx … Read more

UFC-WELTMEISTER JON JONES, LIFECYKEL LABS, CANTERBURY-BANKSTOWN BULLDOGS UND BETTER BREATHING DEVICES VERANSTALTEN ELITE-LEISTUNGSTRAININGSTAG

SYDNEY, 10. Februar 2024 /PRNewswire/ — Jon Jones, UFC-Weltmeister und der wohl beste MMA-Kämpfer aller Zeiten, tourt durch Australien und hat eine Partnerschaft mit Lifecykel Labs geschlossen, um einen erstklassigen Leistungstrainingstag im Heimstadion der Canterbury-Bankstown Bulldogs, dem Belmore Sports Ground, zu organisieren und zu unterstützen. Julian Mitchell, CEO von Lifecykel Labs, erklärte: „Wir fühlen uns … Read more

INSPIRE MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc.

NEW ORLEANS, Feb. 9, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive … Read more

Global Negative Pressure Wound Therapy Market Set to Surge to $3.7 Billion by 2030, Driven by Rising Diabetic Foot Ulcer Cases and Shift Towards Homecare Settings

DUBLIN, Feb. 9, 2024 /PRNewswire/ — The “Global Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By End-Use, By Product, By Type (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others), By Regional Outlook and Forecast, 2023 – 2030” report has been added to  ResearchAndMarkets.com’s offering. The Global Negative Pressure … Read more